MGCPharma

MGCPharma

MGC Pharmaceuticals (ASX: MXC) is a BioPharma company with a focus on Phytocannabinoid medications. The company created a seamless supply chain, from growing through to API level extraction, with global operations that provide proprietary Phytocannabinoid formulations worldwide. MGCPharma has medications currently in clinical trials for treatment areas such as Neurology, Oncology and Palliative Care. With research activities in various fields in Europe, Australia and Israel, MGC Pharma intends to impact global health and wellness via the judicious use of Phytocannabinoid medications. 

Close Menu
×
×

Cart